Berlex Biosciences in San Pablo, CA

Company Name: Berlex Biosciences

Street: 15049 San Pablo Ave

City: San Pablo

State: CA

Postal Code: 94806

Address: 15049 San Pablo Ave, San Pablo, CA, 94806

Explore More Information
  1. JOINN Innovation Park - Biotech Acceleration Campus
    JOINN Innovation Park - Biotechnology Acceleration Campus. JOINN Innovation Park is the emerging biotech campus for life science research and development companies in ...
  2. Pharmaceuticals | Bayer - Home
    Group involved in three major areas of health care, prescription medications, biological products and biotechnology. Also produce allergenic extracts, used by allergy ...
  3. Management Team | Taxus Cardium
    Christopher J. Reinhard, Chairman of the Board and Chief Executive Officer. Mr. Reinhard is co-founder of Cardium and has served as a director and the Chief Executive ...
  4. Christian Beauséjour - Département de pharmacologie ...
    Formation Scientict, Sangamo Biosciences, California, USA (2004-2005) Postdoctoral fellow, Berlex Biosciences, California, USA (2003-2004) Postdoctoral fellow ...
  5. News & Events : Caprion
    News October 4, 2016 Caprion Bioscience to Present “Analytical Challenges and Strategies of Using MRM/MS-Based Methods for Biomarker Development” (PDF)
  6. Board of Directors | About Us | Cleave Biosciences
    Carol Gallagher, Pharm. D. Partner NEW ENTERPRISE ASSOCIATES. Carol Gallagher joined New Enterprise Associates (NEA) in October 2014, where she is primarily focused ...
  7. Leadership Team | About Us | Cleave Biosciences
    Laura Shawver, PhD Chief Executive Officer. Dr. Shawver is an experienced Biotech executive with more than 25 years of experience in the development of small molecule ...
  8. Akarna Therapeutics | Leadership
    Raju is a co-founder of Akarna and has served as our Chief Executive Officer since January 2016 and a member of our board of directors since November 2014.
  9. Michael M. Morrissey, Ph.D. | Exelixis
    President and Chief Executive Officer. Michael M. Morrissey, Ph.D. has served as a director and as Exelixis’ President and Chief Executive Officer since July 2010.
  10. The ubiquitin-conjugating enzyme E2-EPF is overexpressed ...
    1. Neoplasia. 2007 Jul;9(7):601-13. The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to ...

Pages: 1 2

Related Companies